Matthew Allemang
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Matthew Allemang sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).
Matthew Allemang: 2 sponsored US clinical trials, 1 recruiting.
Matthew Allemang sponsors 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Gastroparesis, with 2 trials.
Mid-pack sponsor footprint
Matthew Allemang is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Open and recent trials
2 total, page 1 of 1
Therapeutic Areas
What is open in the Matthew Allemang pipeline
1 recruiting of 2 indexed (50% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Gastroparesis (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Matthew Allemang: open-pipeline peers nationwide
Peers matched on 2 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Matthew Allemang sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 2 trials (± recruiting share)
- 1200 Pharma · 2 trials · 50% recruiting
- 1ST Biotherapeutics · 2 trials · 50% recruiting
- 3 Waves Wellness · 2 trials · 0% recruiting
- 3EO Health · 2 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
- Abcentra · 50% recruiting · 2 trials
Related
What to do with this Matthew Allemang page
2 registered trials is a research-attention snapshot, not an endorsement of Matthew Allemang or any single study.
- 1 of Matthew Allemang's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Gastroparesis is the condition Matthew Allemang studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gastroparesis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Matthew Allemang pipeline card: 2 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.